Background: The added benefit of using near-infrared autofluorescence (NIRAF) during total thyroidectomy (TT) remains controversial. This study investigated whether or not NIRAF results in improved patient outcomes postoperatively.
Materials And Methods: We analyzed 1711 TT patients, reported in nine randomized controlled trials, following a systematic search of five databases. NIRAF was compared to the standard of care (naked eye with/without white light). Outcomes included parathyroid gland (PG) and calcium parameters and other clinical outcomes. For dichotomous outcomes, the log odds ratio (logOR) was calculated, and for continuous outcomes, the crude mean difference (MD) was measured. Sensitivity analysis was performed when heterogeneity was significant. The revised Cochrane risk of bias tool was used to assess the methodological quality.
Results: Compared to the standard of care, the use of NIRAF was associated with a significant reduction in postoperative hypoparathyroidism [logOR=-0.31; 95% CI: -0.57: -0.05], inadvertent PG removal [logOR=-0.93; 95% CI: -1.60: -0.26], and postoperative hypocalcemia [logOR=-0.43 mmol/l; 95% CI: -0.77: -0.09]. It was also associated with significantly higher postoperative PTH levels [MD=4.78 pg/ml; 95% CI: 2.13: 7.43], PG identification rate [logOR=1.02; 95% CI: 0.31: 1.72], postoperative serum calcium [MD=0.05; 95% CI: 0.00: 0.09], and operative time [MD=9.38 min; 95% CI: 6.68: 12.09]. No difference was seen regarding PG autotransplantation, length of hospital stay, and hospitalization due to hypocalcemia. Seven trials had low risk and the remainder had some concerns.
Conclusion: NIRAF is superior to the naked eye in identifying all four PGs during TT. The reduced risk of postoperative hypoparathyroidism and hypocalcemia reflected this preservation value. However, it was not associated with a change in the length of hospital stay. Although rare, the readmission rate due to hypocalcemia was similar across both methods.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11175777 | PMC |
http://dx.doi.org/10.1097/JS9.0000000000001247 | DOI Listing |
Adv Mater
March 2025
State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
Near-infrared afterglow luminescent inorganic nanomaterials (NIR-ALINs) possess the unique property of continuing to emit near-infrared (NIR) luminescence after excitation ceases. They demonstrate excellent photostability, deep tissue penetration, and high imaging signal-to-noise ratio (SNR). Additionally, NIR-ALINs can be re-excited in vivo using visible (Vis), NIR light or X-rays, which avoids the need for continuous in situ excitation, thus eliminating autofluorescence of biological tissues and reducing the tediousness of multiple injections.
View Article and Find Full Text PDFHeliyon
February 2025
Department of Ophthalmology, Capital Medical University Electric Teaching Hospital (State Grid Corporation of China Beijing Electric Power Hospital), No. 1, Xili, Taipingqiao, Fengtai District, Beijing, 100073, China.
Introduction: Phospholipase A2 receptor (PLA2R) is a major target antigen in idiopathic membranous nephropathy (IMN). IMN was often reported to have retinal vascular abnormalities secondary to hypercoagculability or hypertension. We describe a case of a serum anti-PLA2R antibody positive patient with bilateral drusenoid deposits and subretinal fluid (SRF) and cystoid macular edema (CME) to stress the necessity of fundus examination in anti-PLA2R antibody positive or IMN patients.
View Article and Find Full Text PDFFront Surg
February 2025
Department of Thyroid, Breast and Hernia Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Objective: Near-infrared autofluorescence (NIRAF) imaging shows promise in identifying parathyroid gland (PG) during surgery. However, the clinical application of NIRAF faces challenges due to the heterogeneous fluorescence intensity (FI) of PGs observed in different thyroid and parathyroid diseases. This study aimed to evaluate the effectiveness of NIRAF in PG detection and to analyze the FI of PGs in patients with various thyroid and parathyroid diseases.
View Article and Find Full Text PDFAngew Chem Int Ed Engl
March 2025
Nanyang Technological University, School of Chemistry, Chemical Engineering and Biotechnology, 70 Nanyang Drive, 637457, Singapore, SINGAPORE.
Molecular chemiluminescence probes with near-infrared (NIR) emission offer promising benefits in deciphering complex pathological processes in a living system, as NIR chemiluminescence minimizes autofluorescence, enhances deep-tissue penetration, and improves signal-to-noise ratio. Molecular engineering with single luminophore design and dual-luminophore design with intramolecular energy transfer provides way to develop conventional chemiluminophore scaffolds into NIR chemiluminescence probes with ideal chemiluminescence quantum yield and half-life. By virtue of the structural diversity, 1,2-dioxetane-based NIR chemiluminophores with biomarker activity have been developed.
View Article and Find Full Text PDFWorld J Surg
March 2025
Division of Endocrine Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, New York, USA.
Background: Near-infrared autofluorescence (NIRAF) spectroscopy is an emerging adjunct for intraoperative parathyroid identification. However, its ability to differentiate between normocellular, hyperplastic, or adenomatous parathyroids remains unexplored. We hypothesize that parathyroid adenomas have lower NIRAF ratios than normocellular parathyroids since the likely fluorophore is the calcium-sensing receptor (CaSR), which is downregulated in adenomas.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!